SCHEMBL687916

SCHEMBL687916

CC1Cc2c([nH]c3ccccc23)C(C(=O)O)=CN1C(=O)c1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 7/20 0.50
ABCB1 P08183 2/20 0.45
ABCG2 Q9UNQ0 2/20 0.45
CDK4 P11802 1/20 0.44
CCND1 P24385 1/20 0.44
POLB P06746 1/20 0.41
ESR1 P03372 3/20 0.41
CYP2C8 P10632 1/20 0.41
CYP2B6 P20813 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MTHFD2 P13995 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29880554 1.00 NR1H4 (0.50) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL4302795 0.92 ABCG2 (0.43) NR1H4ABCB1ABCG2ESR1MEN1
SCHEMBL29881780 0.89 NR1H4 (0.49) NR1H4ABCB1ABCG2ESR1CYP2C8
SCHEMBL5733404 0.89 NR1H4 (0.49) NR1H4ABCB1ABCG2ESR1CYP2C8
SCHEMBL4299699 0.87 NR1H4 (0.48) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL274556 0.86 NR1H4 (0.69) NR1H4CDK4CCND1POLBMEN1
SCHEMBL273732 0.85 NR1H4 (0.70) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL274941 0.85 NR1H4 (0.45) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL29881127 0.85 NR1H4 (0.70) NR1H4ABCB1ABCG2CDK4CCND1
SCHEMBL274942 0.84 NR1H4 (0.44) NR1H4ABCB1ABCG2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532153-B1 AZEPINOINDOLE AND PYRIDOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS X CEPTOR THERAPEUTICS INC (US) 2012-02-29 EP claimed
US-7595311-B2 Modulating active of receptors; therapy prevention of disease such aas symthrome X, antidiabetic agents, insulin resistance, hypoglycemic agents EXELIXIS, INC. (US) 2009-09-29 US claimed